Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Scheld

Showing results (131-140 of 168) with videos related to

Pageof 17
Sort By:
The Journal of Infectious Diseases|October 1, 1985
Yeast adhesion in the pathogenesis of endocarditis due to Candida albicans: studies with adherence-negative mutantsR A Calderone, R L Cihlar, D D Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1992
Evaluation of new anti-infective drugs for the treatment of toxoplasma encephalitis. Infectious Diseases Society of America and the Food and Drug AdministrationM A Sande, R J Whitley, G H McCracken, et al.
Infection and Immunity|August 1, 1983
Susceptibility of brain to aerobic, anaerobic, and fungal organismsG T Costello, R Heppe, H R Winn, et al.
The American Journal of Medicine|April 27, 1987
Oral ciprofloxacin therapy for gram-negative bacillary osteomyelitisA J Lesse, C Freer, R A Salata, et al.
Medicine|May 1, 1987
Intracranial blastomycomaK L Roos, J P Bryan, W W Maggio, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1981
Moxalactam and cefazolin: comparative pharmacokinetics in normal subjectsW M Scheld, D A Spyker, G R Donowitz, et al.
The Journal of Infectious Diseases|October 1, 1983
Treatment of experimental brain abscess with penicillin and chloramphenicolE C Haley, G T Costello, G T Rodeheaver, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1982
Pharmacokinetics of cefaclor in renal failure: effects of multiple doses and hemodialysisD A Spyker, L L Gober, W M Scheld, et al.
Kidney International|September 1, 1984
Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokineticsJ S Gerig, N D Bolton, E A Swabb, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1980
Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunctionW K Bolton, W M Scheld, D A Spyker, et al.
Pageof 17

Showing results (131-140 of 168) with videos related to

Sort By:
Pageof 17
The Journal of Infectious Diseases|October 1, 1985
Yeast adhesion in the pathogenesis of endocarditis due to Candida albicans: studies with adherence-negative mutantsR A Calderone, R L Cihlar, D D Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1992
Evaluation of new anti-infective drugs for the treatment of toxoplasma encephalitis. Infectious Diseases Society of America and the Food and Drug AdministrationM A Sande, R J Whitley, G H McCracken, et al.
Infection and Immunity|August 1, 1983
Susceptibility of brain to aerobic, anaerobic, and fungal organismsG T Costello, R Heppe, H R Winn, et al.
The American Journal of Medicine|April 27, 1987
Oral ciprofloxacin therapy for gram-negative bacillary osteomyelitisA J Lesse, C Freer, R A Salata, et al.
Medicine|May 1, 1987
Intracranial blastomycomaK L Roos, J P Bryan, W W Maggio, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1981
Moxalactam and cefazolin: comparative pharmacokinetics in normal subjectsW M Scheld, D A Spyker, G R Donowitz, et al.
The Journal of Infectious Diseases|October 1, 1983
Treatment of experimental brain abscess with penicillin and chloramphenicolE C Haley, G T Costello, G T Rodeheaver, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1982
Pharmacokinetics of cefaclor in renal failure: effects of multiple doses and hemodialysisD A Spyker, L L Gober, W M Scheld, et al.
Kidney International|September 1, 1984
Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokineticsJ S Gerig, N D Bolton, E A Swabb, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1980
Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunctionW K Bolton, W M Scheld, D A Spyker, et al.
Pageof 17